Market Cap 1.17B
Revenue (ttm) 63.72M
Net Income (ttm) -193.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -303.69%
Debt to Equity Ratio 0.22
Volume 1,933,800
Avg Vol 1,353,042
Day's Range N/A - N/A
Shares Out 159.02M
Stochastic %K 2%
Beta 1.49
Analysts Strong Sell
Price Target $17.45

Latest News on OCUL

Ocular Is Now Thoroughly Derisked

Dec 30, 2024, 12:16 PM EST - 3 months ago

Ocular Is Now Thoroughly Derisked


Ocular Therapeutix, Inc. (OCUL) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 10:34 AM EST - 5 months ago

Ocular Therapeutix, Inc. (OCUL) Q3 2024 Earnings Call Transcript


Ocular Therapeutix™ to Present at September Retina Meetings

Sep 5, 2024, 7:30 AM EDT - 7 months ago

Ocular Therapeutix™ to Present at September Retina Meetings


Ocular Therapeutix, Inc. (OCUL) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 12:53 PM EDT - 8 months ago

Ocular Therapeutix, Inc. (OCUL) Q2 2024 Earnings Call Transcript


Ocular Therapeutix™ Reports Second Quarter 2024 Results

Aug 7, 2024, 7:10 AM EDT - 8 months ago

Ocular Therapeutix™ Reports Second Quarter 2024 Results


Ocular Therapeutix® to Host Investor Day on June 13, 2024

Jun 5, 2024, 7:30 AM EDT - 10 months ago

Ocular Therapeutix® to Host Investor Day on June 13, 2024


Ocular Therapeutix™ Reports First Quarter 2024 Results

May 7, 2024, 4:05 PM EDT - 11 months ago

Ocular Therapeutix™ Reports First Quarter 2024 Results